GOLDMAN SACHS GROUP INC - ONCTERNAL THERAPEUTICS INC ownership

ONCTERNAL THERAPEUTICS INC's ticker is ONCT and the CUSIP is 68236P107. A total of 87 filers reported holding ONCTERNAL THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.12 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ONCTERNAL THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$12,000
-94.3%
13,161
-93.1%
0.00%
Q2 2022$211,000
-9.4%
189,634
+13.0%
0.00%
Q1 2022$233,000
-38.5%
167,849
+0.5%
0.00%
Q4 2021$379,000
-12.7%
167,028
+60.6%
0.00%
Q3 2021$434,000
+313.3%
103,978
+371.4%
0.00%
Q2 2021$105,000
-88.3%
22,055
-79.6%
0.00%
Q1 2021$899,000
+910.1%
108,096
+706.2%
0.00%
Q2 2019$89,00013,4080.00%
Other shareholders
ONCTERNAL THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 360,000$1,710,0000.88%
APIS CAPITAL ADVISORS, LLC 120,000$570,0000.49%
Parkman Healthcare Partners LLC 415,384$1,973,0000.43%
Altium Capital Management LP 172,218$818,0000.19%
Vigilare Wealth Management 52,535$250,0000.15%
BRIGHTON JONES LLC 332,875$1,581,0000.08%
Ikarian Capital, LLC 200,204$950,0000.08%
IPG Investment Advisors LLC 31,106$147,754,0000.04%
DOWLING & YAHNKE LLC 150,464$715,0000.04%
Jump Financial, LLC 58,225$276,0000.03%
View complete list of ONCTERNAL THERAPEUTICS INC shareholders